Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis …

Ketamine is a dissociative anesthetic used medically for induction and maintenance of anesthesia. It is also used as a treatment for depression and in pain management. [19] Ketamine is an …

Jan 30, 2024 · Ketamine is a racemic mixture of both (R)- and (S)-enantiomers, whereas esketamine consists solely of the (S)-enantiomer. The FDA has approved the esketamine for …

A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D …

Ketamine is a rapid-acting general anesthetic and NMDA receptor antagonist used for induction of anesthesia diagnostic and surgical procedures typically in combination with a muscle relaxant.

Formula: C 13 H 16 ClNO Molecular weight : 237.725 IUPAC Standard InChI: InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8 …

Dec 11, 2024 · The molecular formula of ketamine is C13H16ClNO. It consists of a cyclohexanone ring that is attached to an aromatic carbon (double) bond. Chemically, this is …

Ketamine is a rapid-acting general anaesthetic administered as the hydrochloride by intravenous or intramuscular injection and producing dissociative anaesthesia characterised by profound …

ChemSpider record containing structure, synonyms, properties, vendors and database links for Ketamine, 6740-88-1, Ketolar, YQEZLKZALYSWHR-UHFFFAOYSA-N

Ketamine . Details; Names: Ketamine 2-(2-Chlorophenyl)-2-(methylamino)cyclohexan-1-one: IUPAC name: ... Molecular Formula: C 13 H 16 ClNO: Molecular Weight: 237.7253 g/mol: …